Neurogene Inc. (NGNE) Total liabilities 2018–2025
Neurogene Inc. (NGNE) total liabilities at each fiscal year-end, per SEC filings.
$23.7MFY2025 · since FY2018: $4.9M → $23.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $23.7M | -6.5% |
| FY2024 | $25.4M | -30.6% |
| FY2023 | $36.5M | — |
| FY2018 | $4.9M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More NGNE financial trends
NGNE RevenueNGNE Net incomeNGNE Net marginNGNE Gross profitNGNE Gross marginNGNE Operating incomeNGNE Operating marginNGNE Operating cash flowNGNE Free cash flowNGNE Capital expendituresNGNE Return on equityNGNE Stock buybacksNGNE Dividends paidNGNE Total assetsNGNE Shareholders’ equityNGNE overview →